Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Operating Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Operating Profit (Excl OI) ₹50 Cr₹50 Cr₹49 Cr₹37 Cr₹20 Cr

What is the latest Operating Profit of NATH BIOGENES (INDIA) ?

The latest Operating Profit ratio of NATH BIOGENES (INDIA) is ₹50 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹50 Cr
Mar2024₹50 Cr
Mar2023₹49 Cr
Mar2022₹37 Cr
Mar2013₹20 Cr

How is Operating Profit of NATH BIOGENES (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹50 Cr
0.02
Mar2024 ₹50 Cr
1.99
Mar2023 ₹49 Cr
31.59
Mar2022 ₹37 Cr
87.05
Mar2013 ₹20 Cr -

Compare Operating Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹301.3 Cr -4.5% -7.8% -8.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,989.8 Cr 1.1% -9.5% -24.8% Stock Analytics
KAVERI SEED COMPANY ₹5,250.4 Cr -4.6% -4% 21.7% Stock Analytics
VENKYS (INDIA) ₹1,873.3 Cr -1.7% -8.9% -20.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,167.3 Cr -4.3% -10.7% -22.8% Stock Analytics
INDO US BIOTECH ₹253.1 Cr 1.9% -3.4% -47.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4.5%

-7.8%

-8.3%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses